Add a Post
EGLT : Egalet Corporation Stock Research Report

2017-10-20 - Asif

Egalet Corporation is a fully integrated specialty pharmaceutical company developing, manufacturing and commercializing innovative treatments for pain and other conditions. Given the need for acute and chronic pain products and the issue of prescription abuse, the company focused on bringing non-nar...

PIRS : Pieris Pharmaceuticals Stock Research Report

2017-10-20 - Asif

Pieris Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers and develops Anticalin® protein-based drugs to target validated disease pathways in a unique and transformative way. Pieris' pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment,...

RGLS : Regulus Therapeutics Stock Research Report

2017-10-20 - Asif

Regulus Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class drugs targeting micro RNAs to treat diseases with significant unmet medical need. Regulus was formed in 2007 when Alnylam Pharmaceuticals, Inc., or Alnylam, and Ionis Pharmaceutic...

PSDV : pSivida Corporation Stock Research Report

2017-10-20 - Asif

pSivida Corporation develop sustained-release drug delivery products that deliver drugs at a controlled and steady rate for months or years. pSivida hss developed three of the four sustained-release ophthalmic products currently approved by the U.S. FDA for treatment of back-of-the-eye diseases. Its...

CNAT : Conatus Pharmaceuticals Stock Research Report

2017-10-20 - Asif

Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. The company is developing emricasan, a first-in-class, orally active pan-caspase protease inhibitor, for the treatment of patients with chronic liver disease...

TVIA : TerraVia Holdings Stock Research Report

2017-10-20 - Asif

TerraVia is a food, nutrition and specialty ingredients company that harnesses the power of algae, the origin of all plants. Its innovative platform uses microalgae to produce high-value triglyceride oils, proteins, fibers, micronutrients and other ingredients. The inherent flexibility of its techno...

CRBP : Corbus Pharmaceuticals Holdings Stock Research Report

2017-10-19 - Asif

Corbus Pharmaceuticals is a clinical stage pharmaceutical company, focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases with clear unmet medical needs. Its product anabasum is a novel synthetic oral endocannabino...

OCLR : Oclaro Stock Research Report

2017-10-19 - Asif

During its fiscal year 2017, Oclaro was one of the leading providers of optical components and modules for the long-haul, metro and data center markets. Leveraging more than three decades of laser technology innovation and photonics integration, Oclaro provide differentiated solutions for optical ne...

CTRV : Contravir Pharmaceuticals Stock Research Report

2017-10-19 - Asif

Contravir Pharmaceuticals is a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. Contravir is developing two compounds to treat HBV infection, TXL and CRV431. TXL is a highly potent oral lipid prodr...

BLPH : Bellerophon Therapeutics Stock Research Report

2017-10-19 - Asif

Bellerophon Therapeutics is a clinical-stage therapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Bellerophon's focus is the continued development of its nitr...

DRYS : DryShips Stock Research Report

2017-10-19 - Asif

DryShips Inc., a corporation organized under the laws of the Republic of the Marshall Islands, was formed on September 9, 2004. its principal executive offices are located at 109 Kifisias Avenue and Sina Street, Marousi, GR 151 24 Greece.

Business Development

*Developments related to Ocea...

BW : Babcock & Wilcox Enterprises Stock Research Report

2017-10-19 - Asif

B&W is a leading technology-based provider of advanced fossil and renewable power generation and environmental equipment that includes a broad suite of boiler products, environmental systems, and services for power and industrial uses. B&W specialize in technology and engineering for power generatio...

OCUL : Ocular Therapeutix Stock Research Report

2017-10-19 - Asif

Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its bioresorbable hydrogel-based drug product candidates are designed to provide exte...

VCEL : Vericel Corporation Stock Research Report

2017-10-19 - Asif

Vericel Corporation is a leading developer of patient-specific expanded cell therapies for use in the treatment of patients with severe diseases and conditions. Vericel currently have three U.S. Food and Drug Administration (FDA) approved autologous cell therapy products in the United States. MACI ®...

NTNX : Nutanix Stock Research Report

2017-10-19 - Asif

Nutanix provide a leading next-generation enterprise cloud platform that converges traditional silos of server, virtualization and storage into one integrated solution that can also connect to public cloud services. Its software delivers the agility, scalability and pay-as-you-grow economics of the ...

DXTR : Dextera Surgical Stock Research Report

2017-10-16 - Asif

Dextera Surgical is commercializing and developing the MicroCutter 5/80TM stapler based on its proprietary ‘‘staple-on-a-strip’’ technology intended for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its proprietary ‘‘staple-on-a-strip’’ technology enables it to develop prod...

PTX : Pernix Therapeutics Holdings Stock Research Report

2017-10-16 - Asif

Pernix Therapeutics is a specialty pharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs. Its strategy is to continue to create shareholder value by:

  • growing sales of the existing produ...
SNAP : Snapchat Stock Research Report

2017-10-16 - Asif

Snap Inc. is a camera company.

Snap believe that reinventing the camera represents Its greatest opportunity to improve the way that people live and communicate. Its products empower people to express themselves, live in the moment, learn about the world, and have fun together.

Its flagship pro...

OPK : Opko Health Stock Research Report

2017-10-16 - Asif

Opko Health is a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Its diagnostics business includes BioReference Laboratories (“BioReference”), the nation’s third-largest clinical laboratory with a core genetic testing bu...

DVAX : Dynavax Technologies Stock Research Report

2017-10-16 - Asif

Dynavax Technologies is a clinical-stage immunotherapy company focused on leveraging the power of the body’s innate and adaptive immune responses through toll-like receptor (“TLR”) stimulation. Dynavax current product candidates are being investigated for use in multiple cancer indications, as a va...

BIOC : Biocept Stock Research Report

2017-10-16 - Asif

Biocept is an early stage molecular oncology diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, assays utilizing a standard blood sample, or “liquid biopsy.” its current and planned assays are intended to provide info...

MNKD : MannKind Corporation Stock Research Report

2017-10-16 - Asif

MannKind Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes. Its only approved product, Afrezza, is a rapid-acting inhaled insulin that was approved by the FDA on June 27, 2014 to improve glyce...

SYN : Synthetic Biologics Stock Research Report

2017-10-16 - Asif

Synthetic Biologics is a late-stage clinical stage company focused on developing therapeutics designed to preserve the microbiome to protect and restore the health of patients. Its lead candidates poised for Phase 3 development are: (1) SYN-004 (ribaxamase) which is designed to protect the gut micro...

GERN : Geron Corporation Stock Research Report

2017-10-16 - Asif

Geron Corporation is a biopharmaceutical company that currently supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc., or Janssen. Early clinical data, including molecular responses in essential thrombocythemia, o...

AFMD : Affimed N.V. Stock Research Report

2017-10-15 - Asif

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an innovative approach to cancer treatment that seeks to harness the b...